Accelerating the Drug-Device Development Process

The range of novel and innovative drug-device combination continues to grow. Hear from pharma/biotech industry experts, Asmita Khanolkar and Alie Jahngir, on overcoming the challenges for novel drug-device combination and accelerating the development process through commercialization. They review various aspects of aligning new drug development, device technology platforms, new materials, human factors/patient centric efforts, design for manufacturing and scale-up through pre-clinical, clinical and launch product life cycle management.